Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (21-30 of 327) with videos related to

Pageof 33
Sort By:
Neuropsychiatric Disease and Treatment|March 21, 2009
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's diseaseTiffany W Chow, Bruce G Pollock, Norton W Milgram
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Serum anticholinergic activity and cognition in patients with moderate-to-severe dementiaMarci L Chew, Benoit H Mulsant, Bruce G Pollock
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|May 17, 2003
Serotonin transporter promoter polymorphism in African Americans : allele frequencies and implications for treatmentFrancis E Lotrich, Bruce G Pollock, Robert E Ferrell
Journal of Psychosomatic Research|July 31, 2007
Depression following pegylated interferon-alpha: characteristics and vulnerabilityFrancis E Lotrich, Mordechai Rabinovitz, Patricia Gironda, et al.
Journal of Intelligence|April 27, 2023
Five-Factor Model and DSM-5 Alternative Model of Personality Disorder Profile Construction: Associations with Cognitive Ability and Clinical SymptomsChloe Lau, R Michael Bagby, Bruce G Pollock, et al.
Brain, Behavior, and Immunity|July 21, 2009
Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep qualityAric A Prather, Mordechai Rabinovitz, Bruce G Pollock, et al.
Journal of Pharmacological and Toxicological Methods|September 5, 2021
A calcium fluorescence assay for quantification of cholinergic receptor activity of clinical drugs in serum - comparison with radioactive methodsJosé N Nobrega, Roger Raymond, Tarek K Rajji, et al.
Clinical Neuropharmacology|July 28, 2010
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alphaFrancis E Lotrich, Robert E Ferrell, Mordechai Rabinovitz, et al.
Current Psychiatry Reports|August 18, 2011
Use of lithium in the treatment of bipolar disorder in late-lifeRamsey D'Souza, Tarek K Rajji, Benoit H Mulsant, et al.
Biological Psychiatry|September 20, 2008
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphismFrancis E Lotrich, Robert E Ferrell, Mordechai Rabinovitz, et al.
Pageof 33

Showing results (21-30 of 327) with videos related to

Sort By:
Pageof 33
Neuropsychiatric Disease and Treatment|March 21, 2009
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's diseaseTiffany W Chow, Bruce G Pollock, Norton W Milgram
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Serum anticholinergic activity and cognition in patients with moderate-to-severe dementiaMarci L Chew, Benoit H Mulsant, Bruce G Pollock
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|May 17, 2003
Serotonin transporter promoter polymorphism in African Americans : allele frequencies and implications for treatmentFrancis E Lotrich, Bruce G Pollock, Robert E Ferrell
Journal of Psychosomatic Research|July 31, 2007
Depression following pegylated interferon-alpha: characteristics and vulnerabilityFrancis E Lotrich, Mordechai Rabinovitz, Patricia Gironda, et al.
Journal of Intelligence|April 27, 2023
Five-Factor Model and DSM-5 Alternative Model of Personality Disorder Profile Construction: Associations with Cognitive Ability and Clinical SymptomsChloe Lau, R Michael Bagby, Bruce G Pollock, et al.
Brain, Behavior, and Immunity|July 21, 2009
Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep qualityAric A Prather, Mordechai Rabinovitz, Bruce G Pollock, et al.
Journal of Pharmacological and Toxicological Methods|September 5, 2021
A calcium fluorescence assay for quantification of cholinergic receptor activity of clinical drugs in serum - comparison with radioactive methodsJosé N Nobrega, Roger Raymond, Tarek K Rajji, et al.
Clinical Neuropharmacology|July 28, 2010
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alphaFrancis E Lotrich, Robert E Ferrell, Mordechai Rabinovitz, et al.
Current Psychiatry Reports|August 18, 2011
Use of lithium in the treatment of bipolar disorder in late-lifeRamsey D'Souza, Tarek K Rajji, Benoit H Mulsant, et al.
Biological Psychiatry|September 20, 2008
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphismFrancis E Lotrich, Robert E Ferrell, Mordechai Rabinovitz, et al.
Pageof 33